BOSTON--(BUSINESS WIRE)--PureTech Health plc (“PureTech” or the “Company”, LSE: PRTC), a cross-disciplinary healthcare company developing novel medicines focused on the brain, gut and immune system, today announces that Daphne Zohar, PureTech’s Chief Executive Officer, will be presenting at the Jefferies 2016 Healthcare Conference in New York, NY being held on June 7-10, 2016.
PureTech's presentation is scheduled for Thursday 9 June 2016 at 9:30 am ET and will be followed by a breakout session.
About PureTech Health
PureTech Health (PureTech Health plc, PRTC.L) is a cross-disciplinary healthcare company focused on areas of growing scientific and technical insights that it believes are at an important inflection point, including the central nervous, gastro-intestinal and immune systems, and the interactions and signaling between them. PureTech has a pipeline of more than 30 programs and has approximately 20 clinical studies across its pipeline, targeting multi-billion dollar market opportunities. PureTech’s advanced programs include five with human proof-of-concept and multiple with pivotal or registration study readouts in the next two years. PureTech has over 220 patents and patent applications. PureTech's leading team and board, along with an advisory network of more than 60 expert founder-scientists and advisors across multiple disciplines, gives PureTech access to potentially ground-breaking science and technological innovation. With healthcare undergoing major transformation, PureTech believes it is well positioned to develop and launch medicines for the 21st century. For more information, visit www.puretechhealth.com and connect with us on Twitter.